Abattis Announces Receipt of Cultivation License by LP Partner

- August 21st, 2017

Abattis Bioceuticals and its majority-owned testing and laboratory subsidiary, Northern Vine Canada announced their LP investment partner, Experion Biotechnologies received a cultivation license.

Abattis Bioceuticals (CSE:ATT; OTC:ATTBF) and its majority-owned testing and laboratory subsidiary, Northern Vine Canada announced their Licensed Producer (LP) investment partner, Experion Biotechnologies received a cultivation license.
As quoted in the press release:

“Abattis and Northern Vine would like to congratulate Experion on receiving its cultivation license and officially becoming a legal cannabis producer in British Columbia,” said Robert Abenante, President and CEO of Abattis and Northern Vine.

The cultivation license follows Experion’s construction of an indoor secure storage and processing facility, known as the Mission Site. The Mission Site is approximately 8,300 square feet in total, with a portion being used to grow medical-grade marijuana. Experion has already announced plans to expand its production facility to 40,000 square feet, subject to Health Canada approval.

“This is very positive news for Experion and for Northern Vine,” added Mr. Abenante.

Click here to read the full press release.

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time

Leave a Reply

Your email address will not be published. Required fields are marked *